DMXAA (ASA-404; Vadimezan;NSC 640488); 5,6-Dimethylxantheonone-4-acetic acid

規(guī)格	庫(kù)存	目錄價(jià)	會(huì)員專享價(jià)	數(shù)量
25 mg	In-stock	￥800.00	登錄后可見(jiàn)	- +
50 mg	In-stock	￥1488.00	登錄后可見(jiàn)	- +
100 mg	In-stock	￥2266.00	登錄后可見(jiàn)	- +

規(guī)格

庫(kù)存

目錄價(jià)

會(huì)員專享價(jià)

數(shù)量

25 mg

In-stock

￥800.00

登錄后可見(jiàn)

- +

50 mg

In-stock

￥1488.00

登錄后可見(jiàn)

- +

100 mg

In-stock

￥2266.00

登錄后可見(jiàn)

- +

基本信息

英文名稱	Vadimezan (Synonyms: DMXAA; ASA-404)
中文名稱	2-(5,6-二甲基-9-氧代-9H-氧雜蒽-4-基)乙酸; 5,6-二甲基呫噸酮-4-乙酸; 2,5-己酮可可堿；伐地美生
CAS號(hào)	117570-53-3
分子式	C17H14O4
分子量	282.29
MDL	MFCD00870555
外觀	Light brown powder
儲(chǔ)存條件	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

產(chǎn)品詳情

Vadimezan, also known as DMXAA and ASA404, is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF-alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti-tumor activity of tumor-associated macrophages.

相關(guān)文獻(xiàn)

抱歉，暫時(shí)沒(méi)有相關(guān)文獻(xiàn)

相關(guān)產(chǎn)品

抱歉，暫時(shí)沒(méi)有相關(guān)產(chǎn)品

瀏覽記錄

CL1889

2-(5,6-二甲基-9-氧代-9H-氧雜蒽-4-基)乙酸; 5,6-二甲基呫噸酮-4-乙酸; 2,5-己酮可可堿；伐地美生

117570-53-3 98+% In-stock

￥800.00 25 mg